Astronauts traveling in deep space are exposed to highcharge and energy (HZE) particles from galactic cosmic rays. We have previously determined that irradiation of adult female mice with iron HZE particles induces DNA doublestrand breaks, oxidative damage and apoptosis in ovarian follicles, causing premature ovarian failure. These effects occur at lower doses than with conventional photon irradiation. Ovarian failure with resultant loss of negative feedback and elevated levels of gonadotropin hormones is thought to play a role in the pathophysiology of ovarian cancer. Therefore, we hypothesized that charged-iron-particle irradiation induces ovarian tumorigenesis in mice. In this study, three-month-old female mice were exposed to 0 cGy (sham) or 50 cGy iron ions and aged to 18 months. The 50 cGy irradiated mice had increased weight gain with age and lack of estrous cycling, consistent with ovarian failure. A total of 47% and 7% of mice irradiated with 50 cGy had unilateral and bilateral ovarian tumors, respectively, whereas 14% of mice in the 0 cGy group had unilateral tumors. The tumors contained multiple tubular structures, which were lined with cells positive for the epithelial marker cytokeratin, and had few proliferating cells. In some tumors, packets of cells between the tubular structures were immunopositive for the granulosa cell marker FOXL2. Based on these findings, tumors were diagnosed as tubular adenomas or mixed tubular adenoma/ granulosa cell tumors. In conclusion, charged-iron-particleradiation induces ovarian tumors in mice, raising concerns about ovarian tumors as late sequelae of deep space travel in female astronauts. Ó 2018 by Radiation Research Society
INTRODUCTION
Ovarian cancer is the fifth leading cause of cancer-related death among women (1, 2) . Ninety-percent of malignant ovarian cancers are epithelial and are thought to originate from the ovarian surface epithelium, the fallopian tube epithelium or the uterine epithelium, while 7% are sex cord stromal tumors such as granulosa cell tumors and thecomas (3, 4) . Risk of ovarian cancer increases with higher number of lifetime ovulations. Thus, pregnancies, breast-feeding and hormonal contraceptive use, which reduce the lifetime number of ovulatory cycles, are associated with reduced risk of ovarian cancer (5) (6) (7) . Among environmental exposures, tobacco smoking and ionizing radiation exposure are associated with increased risk of ovarian cancer (6) (7) (8) (9) . Experimental studies show that the ovary is highly susceptible to ionizing radiation-induced tumors. Irradiation of adult mice with high-dose rates of low-linear energy transfer (LET) gamma rays, X rays or protons causes ovarian tumors with maximum prevalence of 40-60% at doses of 0.5 to 1.5 Gy (10, 11) . Consistent with these data in mice, female survivors of the atomic bombs in Japan had increased incidence of ovarian cancer (12, 13) .
During deep space missions, astronauts are exposed to solar particle events (SPE) and galactic cosmic rays (GCR). SPE are composed of 90% protons and 10% other ions. GCR contain a mixture of ions including 1% ions heavier than helium, known as high-charge and energy (HZE) particles (14) . HZE particles have high LET and produce ionization densely along their paths (15, 16) . Approximately 21% of the ionizing radiation dose equivalent of GCR to astronauts in a spacecraft is estimated to come from HZE particles, with 2% coming from iron alone (17) . It is estimated that astronauts will be exposed to 40 cGy absorbed dose of ionizing radiation during a three-year Mars mission (18) . Women made up one-half of the 2013 National Aeronautics and Space Administration (NASA) astronaut class (19) , but very few studies been done to investigate the effects of cosmic radiation on the ovary. We recently showed that charged-iron and oxygen particles are highly damaging to the ovary even at low doses, causing premature ovarian failure (20, 21) . Although destruction of ovarian germ cells by ionizing radiation, chemical toxicants and other experimental manipulations is associated with subsequent development of ovarian tumors (22) (23) (24) , there have been very few studies of ovarian tumor induction by HZE particles. Irradiation of female mice with 43.9 cGy of 290 MeV/u carbon ions (LET 10 keV/lm) increased the incidence of ovarian tumors to 23% from 0% in controls (25) , while 20 cGy of 1 GeV iron ions (LET 148 keV/lm) increased the incidence of ovarian tumors to 8% from 3% in controls (26) . In neither of these studies was any molecular characterization performed on the ovarian tumors that were observed. This constitutes an important data gap, which we addressed in the current study.
We hypothesized that charged-iron-particle irradiation induces epithelial ovarian tumors originating in the ovarian surface epithelial cells. We performed detailed histopathological and immunohistochemical analyses of ovaries of irradiated and control mice 15 months postirradiation.
MATERIALS AND METHODS

Animals
Twelve-week-old C57BL/6J female mice (N ¼ 15/treatment group; Jackson Laboratory, Bar Harbor, ME) were exposed to 0 (sham) or 50 cGy charged-iron particles (LET ¼ 179 keV/lm) at energy of 600 MeV/u and dose rates of 13.5-18.6 cGy/min. The fluence was 1.835 3 10 6 particles/cm 2 . This translates to approximately 0.9 cell traversals for an ovarian surface epithelial cell (area ' 50 lm 2 ) and approximately 1.8 traversals for a primordial follicle oocyte (area ' 113 lm 2) . Irradiations were performed at the NASA Space Radiation Laboratory, Brookhaven National Laboratory (Upton, NY) (27) . Sham-irradiated mice were transported and restrained in the same manner and for the same duration of time as irradiated mice. After irradiation, mice were shipped to and followed for 15 months at the University of California Irvine (UC Irvine) vivarium. Mice were monitored for palpable tumors twice weekly and weighed biweekly initially and weekly after 54 weeks of age. Mice that showed significant (10%) weight loss or palpable tumors larger than 1 cm were sacrificed immediately, instead of at the planned 15-month necropsy time point. Ovaries with attached oviducts were harvested and fixed in Bouin's fixative (Thermo Fisher Scientifice Inc., Waltham, MA) or in 4% paraformaldehyde (Electron Microscopy Sciences) in phosphate buffered saline. All animal procedures were approved by the Institutional Animal Care and Use Committees (IACUC) at both Brookhaven National Laboratory and UC Irvine.
Vaginal Cytology
To evaluate radiation-related changes in estrous cycles, microscopic examination of fresh vaginal lavage fluid obtained in 0.9% sodium chloride (28) was performed for five mice from each group every morning beginning at 12 months postirradiation and continuing for three estrous cycles or day 14 if the mice were not cycling. Mice were housed individually for one week before and while monitoring estrous cycles. To avoid potential estrous cycle-related differences in ovarian end points, vaginal cytology was also performed prior to necropsy at 15 months postirradiation; mice were euthanized on the first day with leukocytic vaginal cytology.
Ovarian Histomorphometric Analysis
Bouin's-fixed ovaries were paraffin embedded and serially sectioned at 5 lm thickness. Paraformaldehyde-fixed ovaries were embedded in Tissue-Tekt optimum cutting temperature (OCT) compound (Electron Microscopy Sciences, Hatfield, PA), stored at -808C and serially cryosectioned at 10 lm thickness. Every tenth serial section was H&E stained with Gill's hematoxylin (Thermo Fisher Scientific) and 1% eosin Y (Sigma-Aldrich). Ovarian sections were examined for abnormalities using light microscopy blind to treatment group by two of the authors, one of whom (GWL) is a board-certified veterinary pathologist. Two perpendicular tumor diameters were measured in the largest tumor cross-section using a calibrated ocular micrometer, and the average of the diameters was used for comparison of tumor size by radiation dose.
Immunohistochemical Analysis
Bouin's-fixed or paraformaldehyde-fixed sections were subjected to antigen retrieval using 10 mmol/l sodium citrate with 0.05% Tweene 20 at 958C, blocked with avidin, biotin blocking reagents and normal goat serum (all from Vectort Laboratories, Burlingame, CA), and incubated with primary antibodies directed against cytokeratin, Ki67, ALDH1 or FOXL2 and secondary antibody, as detailed in Table 1 . Sections were then blocked with 0.3% H 2 O 2 and incubated with ABC reagent (Vector Laboratories). Immunostaining was visualized with diaminobenzidine substrate in peroxide buffer (Roche Diagnostics, Indianapolis, IN). Sections were lightly counterstained with hematoxylin. The following negative controls were included in each immunostaining run: 1. primary antibody without secondary antibody; 2. primary antibody replaced by nonimmune IgG with secondary antibody; 3. secondary antibody without primary antibody. Additional controls included ovarian sections from 8-week-old 50 cGy iron-ions irradiated mice from our previously published study (21) . Scoring of immunostaining was done without knowledge of the treatment groups. Ki67 and FOXL2 immunostaining were only performed on five ovaries per treatment group that had been fixed in paraformaldehyde because Bouin's fixation apparently destroyed or masked the epitope to which these antibodies bind. Cytokeratin and ALDH1 immunostaining were performed using both Bouin's-fixed and paraformaldehyde-fixed ovaries.
The numbers of Ki67 immunopositive and immunonegative cells were counted blind to treatment group in three random 100 3 100 lm fields in three separate sections per each of five ovaries per treatment group. In ovaries with ovarian follicles, only random fields that did not contain follicles were counted. The mean percentage of positive cells per ovary was then calculated.
Statistical Analyses
The effect of radiation on body weight over time postirradiation was analyzed using generalized estimating equations (GEE), a form of general linear model, to adjust for repeated measures within animals. Differences between groups in the number of mice cycling and number with tumors were analyzed using Fisher's exact test. Difference in tumor multiplicity between groups was analyzed using Somers' D test. Maximum tumor diameter in each group was 
RESULTS
Charged-Iron-Particle Irradiation Increase Body Weight Gain and Disrupt Estrous Cycling
After irradiation, body weight was monitored biweekly. Mice irradiated with 50 cGy iron showed a clear, though not statistically significant, trend of greater weight gain over time compared to control mice ( Fig. 1 ; P ¼ 0.06, effect of radiation on body weight, GEE). Estrous cycling was evaluated by vaginal cytology in a subset of five mice per group at 12 months postirradiation. All of the irradiated mice were acyclic, while 3 of 5 control mice cycled, albeit irregularly (P ¼ 0.17, Fisher's exact test). Irradiated mice had predominantly leukocytic vaginal cytology, consistent with metestrus or diestrus, on 97 6 3% of days, while control mice had leukocytic cytology 62 6 10% of days (P ¼ 0.013, Mann-Whitney test).
Charged-Iron-Particle Irradiation Induced Ovarian Tumors
Examination of every tenth ovarian serial section at 15 months postirradiation revealed that 20% of the control mice had a few growing follicles and corpora lutea in the ovaries, consistent with continued estrous cycling in some of these mice ( Fig. 2A) . Follicles and corpora lutea were   FIG. 1 . Charged-iron-particle irradiation leads to increased weight gain with aging. Graph shows the means 6 SEM body weights. Body weight was monitored for up to 15 months after 50 cGy or sham (0 cGy) irradiation at 12 weeks of age. There was a trend towards higher weight gain in the irradiated group beginning 40 weeks postirradiation (P ¼ 0.06, effect of radiation on body weight, GEE). completely absent in irradiated mice (Fig. 2B-D) . Invagination of the ovarian surface epithelium was observed in irradiated mice. Ovaries of irradiated mice without tumors also showed occasional tubular structures (Fig. 2B) , which are very similar to the much more numerous tubules observed in the ovarian tumors ( Fig. 2C and D) . Of the irradiated mice, 47% had unilateral ovarian tumors, which were diagnosed as tubular adenomas, and 7% had bilateral tubular adenomas (Fig. 2C and D) , while only 14% of control mice had unilateral and none had bilateral ovarian tubular adenomas (P , 0.04, Fisher's exact test for presence of tubular adenomas and Somers' D test for tumor multiplicity). No oviductal tumors were noted. In addition to being more numerous, the tumors tended to be larger in the irradiated mice. The average tumor diameter in the largest cross-section was 1,000 6 283 lm in the two controls and 1,996 6 875 lm in the eight irradiated mice with tumors (P ¼ 0.034, t test).
On gross inspection at necropsy, abnormalities were noted in other organs (uterus, spleen, liver, lymph nodes, lung, kidney, pancreas), but there was no difference in the prevalence of any of these gross abnormalities between irradiated and control mice. The highest prevalence of 36% was noted for spleen abnormalities (increased size and/or nodules) in controls.
Charged-Iron-Particle-Radiation-Induced Ovarian Tumors were Epithelial
To further confirm the histopathological diagnosis of tubular adenoma, an epithelial tumor, we performed immunostaining using a pan-cytokeratin antibody (Fig. 3) . At 15 months postirradiation, cells lining the tubular structures in nontumor-bearing ovaries and lining the tubules of the tubular adenomas were cytokeratin positive, confirming that these were epithelial tumors (Fig. 3A-C) . As expected, in sham-irradiated control mice only the single layer of ovarian surface epithelial cells was cytokeratin positive (Fig. 3D) . At 8 weeks after 50 cGy iron-ion irradiation, ovaries were essentially devoid of follicles (21), and only ovarian surface epithelial cells were immunopositive for cytokeratin (Fig. 3E) . We also analyzed proliferation using Ki67 immunostaining in a subset of ovaries (Fig. 4) . In control ovaries (N ¼ 5), Ki67 immunostaining was observed in most granulosa cells of growing follicles (Fig 4C) , but in very few cells in the ovarian stroma (1.2 6 0.8% positive stromal cells/total number of cells). In irradiated ovaries ( Fig. 4A 
SPACE RADIATION CAUSES OVARIAN TUMORS
ALDH1-positive epithelial cells at the junction of the ovarian surface epithelium, mesothelium and oviductal epithelium (the ovarian hilum) have been reported to constitute a cancer-prone stem cell niche from which epithelial ovarian tumors may arise (29) . Therefore, we performed immunostaining for ALDH1. We observed ALDH1 immunopositivity throughout the ovarian stroma and in surface epithelial cells at the hilum, as well as throughout the ovarian surface epithelium, but not in granulosa cells in control ovaries from mice sacrificed at 15 months (Fig. 5A ) and 8 weeks (Fig. 5B) postirradiation. We also observed ALDH1 staining in the ovarian tumors in irradiated mice. Interestingly, ALDH1 staining was observed in the cytokeratin-positive cells lining the tubules, as well as in some tumor areas that were negative for cytokeratin (compare Fig. 3A-C with Fig. 5C-F) .
To determine whether the tumors contained granulosa cell tumor components, we performed immunostaining with a FOXL2 antibody in a subset of ovaries (Fig. 6 ). FOXL2 is a granulosa cell marker used to diagnose granulosa cell ovarian tumors (30) . As expected, FOXL2 immunostaining was detected in the granulosa cells of growing follicles, but very rarely in the ovarian stroma, of sham-irradiated mice (N ¼ 5; Fig. 6A ). FOXL2 immunostaining was not detected in the cytokeratin-positive epithelial cells lining the tubular structures within an ovarian tumor of an irradiated mouse, but was detected in clusters of cells between the tubules that were granulosa cell-like in appearance ( Fig. 6B and C) . A similar cluster of FOXL2-positive cells was observed in a nontumor-bearing ovary of an irradiated mouse (data not shown). Thus, we concluded that some of the ovarian tumors we observed in irradiated mice were mixed tubular adenoma/granulosa cell tumors.
DISCUSSION
We observed a nearly fourfold increase in ovarian tumor prevalence at 15 months after 50 cGy charged-iron-particle irradiation compared to sham irradiation. Ovarian tumors in irradiated mice were also larger than those found in controls. The tumor-bearing ovaries were devoid of follicles, and the tumors were diagnosed as tubular adenomas or mixed tubular adenomas/granulosa cell tumors based on their histology, positive immunostaining for the epithelial marker cytokeratin (31), positive immunostaining for the granulosa cell marker FOXL2 and low numbers of proliferating cells. To our knowledge, this is the first study to report on the immunopathological characterization of ovarian tumors induced by charged-iron particles. Ninety-percent of malignant ovarian tumors in women are epithelial (32) . Thus, it is relevant that the tumors induced by charged-iron particles were epithelial tumors, albeit nonmalignant. Similar to epithelial ovarian cancer in humans, which occurs predominantly in postmenopausal women, tubular adenomas have been shown to occur in multiple experimental rodent models in which ovarian follicle depletion is induced, for example, by ionizing radiation, chemical ovotoxicants, genetic manipulation or other means (22) (23) (24) , as well as in very old animals (33) . On the other hand, tubular adenomas rarely metastasize and do not grow very rapidly. We observed few mitotic figures and few Ki67-positive cells in these tumors, consistent with the nonmalignant nature of tubular adenomas. Thus, tubular adenomas are more similar to human type I epithelial ovarian tumors, which include low-grade serous, endometrioid, clear cell and mucinous carcinomas, than they are to human type II epithelial ovarian tumors, which include high-grade serous carcinoma, carcinosarcoma and undifferentiated carcinoma (34) .
In previously published studies, ALDH1 has been proposed as a marker of ovarian surface epithelial stem cells localized to the hilum (junction between ovarian surface epithelium, ovarian ligament epithelium and oviductal epithelium) by one group (29) , while another group (35) reported that ALDH1 was expressed throughout the ovarian surface epithelium. Our results in controls concur with the latter findings. Moreover, to our knowledge, this is the first reported study of ALDH1 expression in ovarian tubular adenomas. Our observations of high levels of ALDH1 protein in stromal cells and tubular adenoma cells are consistent with the previously published finding that ALDH1 is expressed in both stromal cells and tumor cells in human ovaries, with greater expression in tumor cells associated with well-differentiated tumors that have a better prognosis (36) .
In general, the potency of 50 cGy iron ions for ovarian tumor induction in the current study appears to be higher than similar doses of gamma rays or protons. However, comparisons among studies are limited by the lack of sideby-side comparison of a range of doses of iron ions with photon radiation or protons, as well as by other experimental differences, such as different mouse strains used and different ages at the time of irradiation. The overall ovarian tumor prevalence of 54% is in the range reported for 50 cGy of low-LET X rays (73% at 50 cGy reported by Watanabe et al. and 47% at 50 cGy reported by Clapp), but higher than ovarian tumor prevalence reported for similar doses of gamma rays (25% at 50 cGy, reported by Upton et al.) and protons (17% at 43 cGy reported by Watanabe et al. and 47% at 50 cGy reported by Clapp) (10, 11, 37) . The ovarian tumor prevalence of 54% observed in the current study after 50 cGy charged-iron-particle irradiation is higher than the 8% prevalence reported for 20 cGy iron particles (LET 150 
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keV/lm) in BALB/cByJ mice (26) and higher than the 23% prevalence reported for 44 cGy carbon ions (LET 10 keV/ lm) in B6C3F1 mice (25) . However, due to the lack of dose-response data within studies and the experimental differences noted above, it is not possible to draw definitive conclusions about relative potencies for ovarian tumorigenesis of various charged particles, gamma rays and X rays.
We observed a borderline significant trend for greater body weight gain over time in iron-ion-irradiated mice compared to sham controls. A similar effect of increased weight gain beginning at approximately 150 days postirradiation was previously reported in carbon-ion-irradiated female mice, but not male mice (25) . Continuous exposure to low-dose-rate gamma radiation caused weight gain in male and female B6C3F1 mice, but males gained less weight than females (38) . Increased weight gain on a highfat diet was reported in mice exposed to the ovarian toxicant 4-vinylcyclohexene diepoxide, which also depletes ovarian follicles and causes premature ovarian failure and ovarian tumors (39, 40) . The increased weight gain is likely caused by greatly diminished ovarian estrogen production due to ovarian failure. Although we did not measure circulating estradiol concentrations, we have previously shown that by 8 weeks after 50 cGy iron-ion irradiation almost no ovarian follicles remain and circulating luteinizing hormone (LH) and follicle stimulating hormone (FSH) concentrations are significantly elevated, consistent with loss of ovarian negative feedback due to lack of ovarian estrogen production (21) . Postmenopausal weight gain with increased central adiposity is observed in women, and perimenopausal estrogen replacement prevents the increase in central adiposity (41) . Androgen deprivation therapy for prostate cancer in men is also associated with weight gain (42) .
Elevated concentrations of LH and FSH in postmenopausal women have been postulated to play a role in the pathogenesis of ovarian tumors (43) . Various animal models in which ovarian follicles are depleted, resulting in elevated LH and FSH concentrations, develop ovarian tumors (22, 23, 43) . More direct evidence for a pathogenic role of high LH and FSH concentrations comes from experiments showing that hypogonadal mice, which have a defect in gonadotropin releasing hormone production and therefore do not produce LH and FSH, do not develop ovarian tumors after irradiation (44) mice, which are genetically deficient in ovarian follicles, have high serum LH and FSH concentrations due to lack of ovarian negative feedback and spontaneously develop ovarian tubular adenomas (45) .
In conclusion, our results show that irradiation of adult mice, using charged-iron particles such as those found in galactic cosmic rays, leads to a high prevalence of tubular adenomas and mixed tubular adenoma/granulosa cell ovarian tumors later in life. The tubular adenomas are cytokeratin and ALDH1 positive, consistent with origination from the ovarian surface epithelial cells, which are also considered to be one of the likely cells of origin of epithelial ovarian cancers in humans. Our results raise concerns about the development of ovarian cancer as a possible late adverse sequela in women traveling in deep space.
